Opioid Substitution Treatment

Gender differences in physical morbidity in opioid agonist treatment patients: population-based cohort studies from the Czech Republic and Norway

Scientific article

28 July 2023

Background: Physical health problems are common in people receiving opioid agonist treatment (OAT). A study was conducted on these health issues in OAT patients in the Czech Republic and Norway from 2010 to 2019, with a focus on gender...

Recovery is Possible: Defining Recovery in terms of abstinence-based treatment and Opioid substitution therapy

ISSUP Webinar

26 September 2022

ISSUP South Africa are pleased to present their Webinar on Defining Recovery in terms of abstinence-based treatment and Opioid substitution therapy.

Recovery is Possible: Defining Recovery in terms of abstinence-based treatment and Opioid substitution therapy

26 September 2022

Pretoria

South Africa

ISSUP South Africa would like to invite you to their upcoming Webinar on Defining in terms of -based and Opioid substitution therapy.

Implementation of Opioid Substitution Therapy in South Africa

10 May 2022

Johannesburg

South Africa

You are invited to attend an upcoming webinar meeting aiming to discuss the role of the government agencies in the design and implementation of the HIV interventions among people who use drugs, particularly opioid substitution therapy (OST), in South Africa.

Methadone maintenance treatment

Book

10 November 2021

Document of the Ministry of Health and Social Protection of Colombia that presents baseline of the maintenance programs with methadone in the country and the profile of the population served and the general characteristics of the treatment...

Balancing access to opioid substitution treatment (OST) with preventing the diversion of opioid substitution medications in Europe

Book

This report reviews how opioid substitution treatment (OST) is implemented in European countries and examines the public health consequences of the diversion and misuse of prescription OST medications. It looks at how OST medications are...

Effectiveness Bank Analysis: UPDATED Long-Acting Buprenorphine an Advance on Daily Doses

Scientific article

22 February 2019

*Updated with UK licensing information and advice released in February 2019 by the National Institute for Health and Care Excellence* What could prove a technical advance in the medication-based treatment of dependence on heroin and allied...

How to Deliver Effective Opioid Substitute Treatment in Prisons

Video and audio recordings

11 December 2018

This webinar focuses on: Overcoming organisational and cultural issues Stabilisation and assisted withdrawal Retox and continuity of care Presenters: Dr Joss Bray, Clinical Lead for Drug and Alcohol Treatment in the North East Prisons for...

Webinar: How to Deliver Effective Opioid Substitute Treatment in Prisons

10 December 2018

Webinar

The Substance Misuse Management in General Practice (SMMGP) is hosting a free webinar on Monday the 10th of December at 7 pm.

Risk Factors for Discontinuation of Treatment for Opioid Use Disorders

Scientific article

7 September 2018

Opioid Use Disorder (OUD), and the associated risk of overdose and death, is becoming one of the most prevalent threats to health and social wellbeing in the United States. Medication, such as buprenorphine, is the gold standard treatment...